Publication | Open Access
Dorzagliatin in drug-naïve patients with type 2 diabetes: a randomized, double-blind, placebo-controlled phase 3 trial
87
Citations
39
References
2022
Year
Metabolic SyndromeDiabetes ManagementPlacebo-controlled Phase 3Drug-naïve PatientsDiabetesPharmacologyType 2PharmacotherapyDiabetes MellitusMedicineDrug Discovery
| Year | Citations | |
|---|---|---|
Page 1
Page 1